Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002410971 | SCV002717526 | uncertain significance | Cardiovascular phenotype | 2024-10-19 | criteria provided, single submitter | clinical testing | The p.I645T variant (also known as c.1934T>C), located in coding exon 11 of the SOS1 gene, results from a T to C substitution at nucleotide position 1934. The isoleucine at codon 645 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV003427475 | SCV004145973 | uncertain significance | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | SOS1: PM2 |
Gene |
RCV003427475 | SCV005201267 | uncertain significance | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing | Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 29493581) |
Mayo Clinic Laboratories, |
RCV003427475 | SCV005411671 | uncertain significance | not provided | 2024-02-20 | criteria provided, single submitter | clinical testing | PP2 |